USA - engelsk - NLM (National Library of Medicine)

merus labs international inc. - gemifloxacin mesylate (unii: x4s9f8rl01) (gemifloxacin - unii:okr68y0e4t) - gemifloxacin 320 mg - factive is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (see dosage and administration and clinical studies. ) acute bacterial exacerbation of chronic bronchitis (abecb) caused by streptococcus pneumoniae, haemophilus influenzae, haemophilus parainfluenzae, or moraxella catarrhalis . because fluoroquinolones, including factive, have been associated with serious adverse reactions (see warnings ) and for some patients abecb is self-limiting, reserve factive for treatment of abecb in patients who have no alternative treatment options. community-acquired pneumonia (of mild to moderate severity) caused by streptococcus pneumoniae (including multi-drug resistant strains [mdrsp])*, haemophilus influenzae, moraxella catarrhalis, mycoplasma pneumoniae, chlamydia pneumoniae, or klebsiella pneumoniae . *mdrsp: multi-drug resistant s

USA - engelsk - NLM (National Library of Medicine)

vansen pharma inc. - gemifloxacin mesylate (unii: x4s9f8rl01) (gemifloxacin - unii:okr68y0e4t) - gemifloxacin 320 mg - factive is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (see dosage and administration and clinical studies . ) acute bacterial exacerbation of chronic bronchitis caused by streptococcus pneumoniae, haemophilus influenzae, haemophilus parainfluenzae, or moraxella catarrhalis . community-acquired pneumonia (of mild to moderate severity) caused by streptococcus pneumoniae (including multi-drug resistant strains [mdrsp])*, haemophilus influenzae, moraxella catarrhalis, mycoplasma pneumoniae, chlamydia pneumoniae, or klebsiella pneumoniae . *mdrsp: multi-drug resistant streptococcus pneumoniae , includes isolates previously known as prsp (penicillin-resistant streptococcus pneumoniae ), and are strains resistant to two or more of the following antibiotics: penicillin (mic ≥2 μg/ml), 2nd generation cephalosporins (e.g., cefuroxime), macrolides, tetracyclines and trimethoprim/sulfamethoxazole. to reduce the development

USA - engelsk - NLM (National Library of Medicine)

oscient pharmaceuticals - gemifloxacin mesylate (unii: x4s9f8rl01) (gemifloxacin - unii:okr68y0e4t) - tablet - 320 mg - factive is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (see dosage and administration and clinical studies . ) acute bacterial exacerbation of chronic bronchitis caused by streptococcus pneumoniae, haemophilus influenzae, haemophilus parainfluenzae, or moraxella catarrhalis . community-acquired pneumonia (of mild to moderate severity) caused by streptococcus pneumoniae (including multi-drug resistant strains [mdrsp])*, haemophilus influenzae, moraxella catarrhalis, mycoplasma pneumoniae, chlamydia pneumoniae, or klebsiella pneumoniae . *mdrsp: multi-drug resistant streptococcus pneumoniae , includes isolates previously known as prsp (penicillin-resistant streptococcus pneumoniae ), and are strains resistant to two or more of the following antibiotics: penicillin (mic ≥2 μg/ml), 2nd generation cephalosporins (e.g., cefuroxime), macrolides, tetracyclines and trimethoprim/sulfamethoxazole. to reduce the development

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pahang pharmacy sdn. bhd. - gemifloxacin mesylate -

Canada - engelsk - Health Canada

oscient pharmaceuticals corporation - gemifloxacin (gemifloxacin mesylate) - tablet - 320mg - gemifloxacin (gemifloxacin mesylate) 320mg - quinolones

Namibia - engelsk - Namibia Medicines Regulatory Council

pharmacare limited - gemifloxacin mesylate - tablet - each tablet contains gemifloxacin mesylate equivalent to gemifloxacin 320,0 mg

Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

和聯生技藥業股份有限公司 台北市敦化北路３１１號５樓 (04270075) - gemifloxacin mesylate - 膜衣錠 - gemifloxacin mesylate (0812701210) (320)mg - gemifloxacin - 慢性支氣管炎之急性惡化、社區型肺炎。

Canada - fransk - Health Canada

oscient pharmaceuticals corporation - gémifloxacine (mésylate de gémifloxacine) - comprimé - 320mg - gémifloxacine (mésylate de gémifloxacine) 320mg - quinolones

Kenya - engelsk - Pharmacy and Poisons Board

krishna chemists ltd 3rd floor metrix hardware, lusaka road, - gemifloxacin tablets - film-coated tablet - gemifloxacin tablets 320 mg - gemifloxacin

Bahrain - engelsk - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

hamad town pharmacy - gemifloxacin mesylate - tablet - 320